Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03084705 · ClinicalTrials.gov registry record · NA

Wearable Device for Motivating Hand Use After Stroke

A NA study, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT03084705: Completed NA study, sponsored by University of California, Irvine.

NCT03084705 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03084705, a NA study, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

The goal of this study is to determine the effectiveness of interactive feedback from a wearable device that senses hand function, the Manumeter, in improving upper extremity function in a pilot, randomized controlled trial with chronic stroke patients

Primary Outcome

To measure unilateral gross manual dexterity

Interventions

  • DEVICE Manumeter

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2018-03-07
Est. Completion 2020-01-13
Phase NA
University of California, Irvine

368 total trials

What the finished NCT03084705 record still lists

NCT03084705 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Manumeter is the first listed.

NCT03084705 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03084705 about?

NCT03084705 is a clinical study titled "Wearable Device for Motivating Hand Use After Stroke". The goal of this study is to determine the effectiveness of interactive feedback from a wearable device that senses hand function, the Manumeter, in improving upper extremity function in a pilot, randomized controlled trial with chronic stroke patients

What is the current status of trial NCT03084705?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2018-03-07. Estimated completion is 2020-01-13.

What interventions are being tested in trial NCT03084705?

The interventions under investigation include: Manumeter (DEVICE).

Who is sponsoring clinical trial NCT03084705?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03084705's enrollment target sits among peer trials

17 1871st of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03084705, the US trial registry maintained by the National Library of Medicine. NCT03084705 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.